Kepos Capital LP Biogen Inc. Transaction History

Kepos Capital LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$268.85 - $341.04 $1.02 Million - $1.29 Million	-3,788 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$220.06 - $304.07 $833,587 - $1.15 Million	3,788 New	3,788 $1.12 Million
Q2 2019 Aug 13, 2019	SELL	$219.29 - $241.72 $5.65 Million - $6.23 Million	-25,761 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$216.71 - $338.96 $1.1 Million - $1.73 Million	5,097 Added 24.67%	25,761 $6.09 Million
Q4 2018 Feb 13, 2019	BUY	$278.5 - $352.75 $472,614 - $598,616	1,697 Added 8.95%	20,664 $6.22 Million
Q3 2018 Nov 13, 2018	SELL	$293.51 - $383.83 $463,158 - $605,683	-1,578 Reduced 7.68%	18,967 $6.7 Million
Q2 2018 Aug 13, 2018	BUY	$257.52 - $306.91 $690,411 - $822,825	2,681 Added 15.01%	20,545 $5.96 Million
Q1 2018 May 14, 2018	BUY	$260.13 - $367.91 $779,609 - $1.1 Million	2,997 Added 20.16%	17,864 $4.89 Million
Q4 2017 Feb 12, 2018	BUY	$307.64 - $344.58 $1.73 Million - $1.93 Million	5,615 Added 60.69%	14,867 $4.74 Million
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $2.6 Million - $3.05 Million	9,252	9,252 $2.9 Million

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.6B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Kepos Capital LP, based on Form 13F filings with the SEC.

Stay updated on Kepos Capital LP with notifications on news.